Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > new BUY rating : price target 11$

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Apr 06, 2021 8:39am

38 Views

Post# 32940301

RE:new BUY rating : price target 11$

Wow, so your pumping has come down from "$50 easy" to "possible $100" all the down to $22 and now $11 which is lower than the rights offering 2 year ago. You've done a great job pumping and the company is executing on all cylinders. 66% loss since the recap and going down

realstocky wrote:
LMNL Analyst Ratings

Consensus Buy

Based on 4 analysts offering recommendations for lmnl in the last 3 months.

Analyst Firms Making Recommendations

BLOOM BURTON&CO

ECHELON WEALTH

H C WAINWRIGHT

PIPER SANDLER

Analyst

$11

https://www.nasdaq.com/market-activity/stocks/lmnl/analyst-research